UTHR•benzinga•
JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $355
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 21, 2025 by benzinga